This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04027/identifier/chebi/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04027/identifier/kegg-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04027/identifier/pdb/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04027/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB04027/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04027/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04027
rdf:type
n5:Drug
n5:description
An essential amino acid that is physiologically active in the L-form. [PubChem]
n5:group
experimental
owl:sameAs
n10:DB04027 n12:DB04027
dcterms:title
D-Arginine
adms:identifier
n4:46506552 n7:DAR n8:5287702 n13:DB04027 n14:C00792 n15:15816
n5:synthesisReference
Kyriakos Makryaleas, Karlheinz Drauz, Andreas Bommarius, "Method for the preparation of D-arginine and L-ornithine." U.S. Patent US5591613, issued April, 1995.
n5:IUPAC-Name
n6:271B59F2-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B59F8-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B59F7-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B59F4-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B59F5-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B59F6-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B59F0-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B59EE-363D-11E5-9242-09173F13E4C5 n6:271B59F1-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B59EF-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B59FE-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B59FF-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B59F9-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B59FA-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B59FC-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B59FB-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B59FD-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
157-06-2
n5:Bioavailability
n6:271B5A04-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5A06-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5A07-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5A03-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5A02-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5A05-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B59F3-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5A00-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5A01-363D-11E5-9242-09173F13E4C5